Company / Revenue
ATOSSA THERAPEUTICS, INC. Revenue History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$1.8K
FY2016
5-year range
$1.5K / $632.6K
FY2012-FY2016
Trend
-95.6%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $632,558 to $1,758 over the past 2 years.
Based on SEC 10-K filings.
$1,758 in FY2016 with a 3-year CAGR of -84.6%.
Declined from $632,558 to $1,758 over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -84.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -84.6%, indicating a declining trend.
- In FY2016, revenue decreased 95.6% year-over-year.
- Peak revenue was recorded in FY2014.
- Lowest revenue in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | $1.8K | -95.6% |
| FY2015 | $40.1K | -93.7% |
| FY2014 | $632.6K | +31.3% |
| FY2013 | $481.8K | +32022.8% |
| FY2012 | $1.5K | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026